Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Gender disparities in the National Institutes of Health funding for gastrointestinal oncology. Evaluating novel therapies and circulating tumor DNA (ctDNA) as a marker of response in curatively ...
Phase II Study of Paclitaxel Plus Gemcitabine in Refractory Germ Cell Tumors (E9897): A Trial of the Eastern Cooperative Oncology Group PURPOSE: To characterize the clinical and biologic features of ...
From 1984 to 2000, 124 patients with a retroperitoneal sarcoma were referred to our center for the treatment of the primary tumor or the first local recurrence. These sarcomas were 58 liposarcomas (21 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results